Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

NCT01087580 2017-03-03

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00598858 2016-12-08

2007-5904

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Phase 3 Withdrawn

BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT01685489 2015-10-27

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Phase 1 Withdrawn

Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT01478308 2013-03-06

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00811031 2012-07-30

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

2007-5904

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)